Informed consent was obtained from all patients.
Dipyridamole Echocardiography Two-dimensional echocardiographic and 12-lead electrocardiographic monitorings were performed in combination with dipyridamole infusion15: 0.56 mg/kg over 4 minutes, no dose for 4 minutes, and then 0.28 mg/kg over 2 minutes. The cumulative dose was 0.84 mg/kg over 10 minutes. Aminophylline (70-240 mg over 1-3 minutes) was always given, either at the end (15 minutes) of a negative test or in the presence of an obvious new dyssynergy.
Two-dimensional echocardiograms were continuously recorded during and for as long as 10 minutes after dipyridamole administration. Commercially available, wide-angle, phased-array imaging systems (model 77020 AC, Hewlett-Packard 3.5-MHz transducer; SSH-160 A, Toshiba Sonolayer Alfa 2.5-and 3.75-MHz transducers) were used.
A wall motion score index was derived for rest and peak dipyridamole echocardiograms in each patient. The left ventricle was divided into 13 segments.17 Segmental wall motion was graded as normal, normal motion at rest with normal or increased wall motion (hyperkinesia) after dipyridamole (score, 1); hypokinetic, marked reduction of endocardial motion (score, 2); akinetic, virtual absence of inward motion (score, 3); or dyskinetic, paradoxic wall motion away from the center of the left ventricle in systole (score, 4). The wall motion score index was derived by summation of individual segment scores divided by the number of interpreted segments. Inadequately visualized segments were not scored.
Relation of wall motion abnormalities to coronary artery perfusion was assessed according to the method of Feigenbaum.18 Positivity of the test was linked to detection of marked worsening of wall motion (change of one level or more) in the same area showing asynergy at rest in at least one view. The increase in asynergy from baseline was considered in terms of either severity (e.g., hypokinesia to dyskinesia) or extension (e.g., new wall motion abnormalities of directly adjacent segments). We have previously described the very high interobserver agreement with diagnosis achieved in our laboratory. 16 flex coronary artery, or right coronary artery or its branches. Stenosis severity was estimated in the projection in which it was most severe. The infarctrelated artery was identified by consideration of the electrocardiogram and the location of wall motion abnormalities on ventriculography. Anterograde flow in the infarct-related artery was graded in accordance with the criteria described by the Thrombolysis in Myocardial Infarction (TIMI) investigators.3 Angiographic reperfusion of the infarct-related artery in the present study was defined as TIMI grade 2 or 3.
Collateral vessels were determined to be present if any segment of the infarct-related artery filled in by any manner other than continuous anterograde.
Statistical Analysis
Continuous data are expressed as mean-SD values. Differences between paired data were analyzed by two-tailed paired t test, and differences between groups were analyzed by unpaired t test. Nonparametric differences were examined using a x' test. Sensitivity and specificity were evaluated according to standard definitions. A probability value of less than 0.05 was considered to be statistically significant.
Results

Patient Characteristics
The electrocardiographic localization of acute myocardial infarction was anterior in 30, inferior in 43, and lateral in three patients. Ten patients had a non-Q wave infarction (five anterior and five inferior). Thirty-two patients had one-vessel, 24 had twovessel, 10 had three-vessel, and five had nonsignificant coronary artery disease.
Dipyridamole Echocardiographic Findings
All patients had asynergy at the basal echocardiographic study. There was no complication during We have previously shown that dipyrid& cardiography is feasible and safe after unc acute myocardial infarction.16 It can r noninvasively identify one of the most diagnostic concerns regarding these patie vessel involvement. The present study dipyridamole echocardiography can also anatomy of the infarct-related vessel, which can be reliably inferred from the mechanical behavior of the infarct zone during stress. In fact, dipyridamoleinduced worsening of a resting dyssynergy and the extension of the dyssynergy to the adjacent zone were invariably associated with two angiographic patterns of the infarct-related vessel -patency of the vessel with critical residual stenosis or total occlusion of the vessel with the presence of collateral circulation. These two angiographic patterns might represent the anatomic background for the occurrence of dipyridamole-induced flow maldistribution phenomena. A tight stenosis might provoke vertical steal phenomena with subendocardial underperfusion in the presence of relative subepicardial overperfusion. Second, we used a semiqualitative analysis of the stress echocardiography results. This approach has both merits and limitations. It is known that the wall motion score index provides an integrated estimation of the extent and severity of left ventricular dysfunction. It does not require computer facilities, and it is simple and easy to obtain. Certainly, the subjective analysis by a single observer has the drawback of being operator dependent; this is a potential limitation of the study. However, the accuracy and reproducibility of stress echocardiography readings have been demonstrated to be very high in experienced hands. 23 Last, another possible problem relates to the "tethering" effect (i.e., the possibility that the dipyridamole-induced changes in wall motion might be results of mechanical factors or changes in loading conditions rather than true ischemia). However, this possibility seems unlikely in the model that we studied for several reasons. First, some experimental stud$es have shown that the mechanical effects of an ischemic region extend only to regions immediately adjacent to an ischemic zone, a zone of mild hypofunction that extends less than 1 cm from the ischemic border.24,25 Second, systemic hemodynamic and, in particular, blood pressure changes are trivial with dipyridamole infusion as extensively documented by large-scale clinical experience and invasive hemodynamic studies.26 Third, after dipyridamole, the normal mechanical behavior in the infarct zone consists of unchanged27 or even increased motion and thickening, probably results of the inotropic effect of increased flow.26,28 Fourth, in the patients undergoing angioplasty, the mechanical correction of the stenosis in the infarct-related vessel induced a complete resolution of the dipyridamole-induced dyssynergy, suggesting that the abnormal response to dipyridamole is related to ischemia.
Clinical Implications
There are few nonangiographic methods with which to predict viability after thrombolysis, and they require expensive and sophisticated technology.14 The present study demonstrates that dipyridamole echocardiography provides a simple method with which to identify the presence of jeopardized but viable myocardium after thrombolysis. This represents crucial information in uncomplicated patients who have had intravenous thrombolytic therapy, because it allows a better selection of patients who might benefit from further intervention. The feasibility, safety, low cost, and availability of dipyridamole echocardiography make this technique a simple and useful tool that may be incorporated in the acute management of patients with myocardial infarction whenever the expertise required for stress echocardiography is available.
